查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2067687

精準醫療市場規模、佔有率和趨勢分析報告：按應用、最終用途、地區和細分市場分類（2026-2033 年）

Precision Medicine Market Size, Share & Trends Analysis Report By Application (Diagnostics, Therapeutics), By End Use (Home Care, Hospitals, Clinical Laboratories), By Region (Asia Pacific, North America), And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

精準醫療市場概述

全球精準醫療市場預計到 2025 年將達到 1165.7536 億美元，預計到 2033 年將達到 4051.0604 億美元，2026 年至 2033 年的複合年成長率為 16.99%。

該行業的特點是先進創新和技術的融合，其中基因組學、分子診斷和數據分析的進步在塑造市場發展中發揮核心作用。

多體學數據、臨床資訊和真實世界證據的整合，能夠更全面地了解疾病機制和患者差異，從而促進制定高度針對性的治療策略。

此外，伴隨診斷和基於生物標記的方法日益普及，正在加強診斷與治療的整合，從而實現更精準的患者篩選和更佳的治療效果。該市場也正經歷重要的策略性佈局，包括生技公司、製藥廠商、診斷服務供應商和科技公司之間的合作、夥伴關係和收購，旨在拓展產品系列、提升研發能力並擴大企業發展。同時，不斷完善的法規結構正在為先進診斷技術的安全性、有效性和臨床有效性制定標準，加速個人化療法的開發和商業化進程。

雲端運算、數位健康平台和先進生物資訊解決方案的日益普及，進一步加速了該產業的成長。醫療服務提供者、研究機構和生命科學公司正擴大利用整合數位生態系統，以高效管理、分析和解讀海量的基因組和臨床數據。預測模型和先進分析工具的應用，正在改善患者分層、疾病風險評估和治療最佳化，從而實現更準確、更及時的臨床決策。此外，對精準腫瘤學、罕見疾病治療和群體基因組學分析舉措的投入不斷增加，正在推動基於患者特異性基因譜的個人化治療方案的開發。醫療系統、基因組資料庫和數位診斷平台之間互通性的增強，也提高了數據的可近性和臨床整合性。隨著技術能力的不斷發展和在醫療系統中的廣泛應用，預計該行業將在預測期內保持持續成長。

該行業的特點是先進創新與技術的融合，其中基因組學、人工智慧和數據分析的進步在塑造其發展進程中發揮核心作用。多體學數據、臨床資訊和真實世界證據的整合，有助於更全面地了解疾病路徑和患者個體差異。此外，伴隨診斷和基於生物標記的方法日益普及，加強了診斷和治療之間的協調，從而實現更具針對性的治療方法。該市場也見證了生物技術公司、製藥公司和診斷服務供應商之間積極的策略活動，包括透過夥伴關係、收購和協作來擴展自身能力和地理覆蓋範圍。此外，法律規範也不斷完善，以支持個人化療法的開發和商業化，並確保先進診斷工具的安全、有效和標準化。

雲端運算、數位健康平台和先進生物資訊解決方案的日益普及，進一步加速了該產業的成長。醫療機構和研究機構正擴大利用整合數位生態系統，以更有效率地管理和分析海量的基因組和臨床數據。預測分析和機器學習演算法的應用，正在加速患者分層、疾病風險評估和治療方法最佳化，從而實現更精準、更及時的臨床干預。此外，對精準腫瘤學、罕見疾病研究和人群基因組分析舉措的投入不斷增加，也為開發針對個別基因譜的客製化治療方案提供了支持。隨著醫療系統和基因組資料庫之間互通性的不斷提升，預計在預測期內，提供可擴展的、數據驅動的個人化醫療解決方案的能力將顯著增強。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 精準醫療市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 商業環境分析

第4章 精準醫療市場：按應用領域分類的業務分析

  • 按應用領域分類的市場佔有率，2025 年和 2033 年
  • 市場規模、預測與趨勢分析：按應用領域分類，2021-2033年
  • 診斷
  • 治療

第5章 精準醫療市場：依最終用途分類的業務分析

  • 按最終用途分類的市場佔有率，2025 年和 2033 年
  • 市場規模、預測和趨勢分析：按最終用途分類，2021-2033 年
  • 居家照護
  • 醫院
  • 臨床實驗室
  • 其他

第6章 精準醫療市場：區域估算與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第7章 競爭情勢

  • 參與企業概況
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介列表
    • F. Hoffmann-La Roche Ltd
    • Siemens
    • Janssen Global Services, LLC
    • Illumina, Inc.
    • Quest Diagnostics Incorporated
    • 23andMe, Inc.
    • NeoDiagnostix
    • Myriad Genetics
    • Medtronic
    • GE Healthcare
    • Abbott
    • QIAGEN
Product Code: GVR-2-68038-612-7

Precision Medicine Market Summary

The global precision medicine market size was estimated at USD 116,575.36 million in 2025 and is projected to reach USD 405,106.04 million by 2033, growing at a CAGR of 16.99% from 2026 to 2033. The industry is characterized by a high degree of innovation and technological convergence, with advancements in genomics, molecular diagnostics, and data analytics playing a central role in shaping market evolution.

The integration of multi-omics data, clinical information, and real-world evidence is enabling a more comprehensive understanding of disease mechanisms and patient variability, supporting the development of highly targeted treatment strategies.

In addition, the increasing adoption of companion diagnostics and biomarker-based approaches is strengthening the integration between diagnostics and therapeutics, enabling more precise patient selection and improved treatment outcomes. The market is also witnessing significant strategic activity, including collaborations, partnerships, and acquisitions among biotechnology companies, pharmaceutical manufacturers, diagnostic providers, and technology firms aimed at expanding product portfolios, research capabilities, and geographic reach. Furthermore, evolving regulatory frameworks are supporting the development and commercialization of personalized therapies by establishing standards for safety, efficacy, and clinical validation of advanced diagnostic technologies.

The growing adoption of cloud computing, digital health platforms, and advanced bioinformatics solutions is further accelerating the growth of the industry. Healthcare providers, research institutions, and life sciences companies are increasingly leveraging integrated digital ecosystems to efficiently manage, analyze, and interpret large volumes of genomic and clinical data. The use of predictive modeling and advanced analytical tools is improving patient stratification, disease risk assessment, and therapy optimization, enabling more accurate and timely clinical decision-making. In addition, rising investments in precision oncology, rare disease therapeutics, and population genomics initiatives are supporting the development of individualized treatment pathways based on patient-specific genetic profiles. Expanding interoperability between healthcare systems, genomic databases, and digital diagnostic platforms is also improving data accessibility and clinical integration. As technological capabilities continue to advance and adoption increases across healthcare systems, the industry is expected to witness sustained expansion over the forecast period.

The industry is characterized by a high degree of innovation and technological convergence, with advancements in genomics, artificial intelligence, and data analytics playing a central role in shaping its evolution. The integration of multi-omics data, clinical information, and real-world evidence is enabling a more comprehensive understanding of disease pathways and patient variability. In addition, the increasing adoption of companion diagnostics and biomarker-based approaches is strengthening the linkage between diagnostics and therapeutics, allowing for more targeted treatment selection. The market is also witnessing strong strategic activity, including collaborations, partnerships, and acquisitions among biotechnology firms, pharmaceutical companies, and diagnostic providers to expand capabilities and geographic presence. Furthermore, regulatory frameworks are evolving to support the development and commercialization of personalized therapies, ensuring the safety, efficacy, and standardization of advanced diagnostic tools.

The growing adoption of cloud computing, digital health platforms, and advanced bioinformatics solutions is further accelerating the expansion of the industry. Healthcare providers and research organizations are increasingly leveraging integrated digital ecosystems to manage and interpret large volumes of genomic and clinical data more efficiently. The use of predictive analytics and machine learning algorithms is enhancing patient stratification, disease risk assessment, and therapy optimization, enabling more precise and timely clinical interventions. In addition, rising investments in precision oncology, rare disease research, and population genomics initiatives are supporting the development of customized treatment pathways tailored to individual genetic profiles. As interoperability between healthcare systems and genomic databases continues to improve, the ability to deliver scalable and data-driven personalized healthcare solutions is expected to strengthen significantly over the forecast period.

Global Precision Medicine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global precision medicine market report based on application, end use, and region:

  • Application Outlook (Revenue, USD Million; 2021 - 2033)
  • Diagnostics
    • Genetic Tests
    • Direct to Consumer Tests
    • Esoteric Tests
    • Others
  • Therapeutics
    • Pharmaceuticals
    • Oncology
    • Respiratory Diseases
    • Skin Diseases
    • CNS Disorders
    • Immunology
    • Genetic Diseases
    • Others
    • Medical Devices
    • Others
  • End-use Outlook (Revenue, USD Million; 2021 - 2033)
  • Home Care
  • Hospitals
  • Clinical Laboratories
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • Kuwait
    • UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Precision Medicine Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pricing Analysis

Chapter 4. Precision Medicine Market: Application Business Analysis

  • 4.1. Application Market Share, 2025 & 2033
  • 4.2. Application Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 4.4. Diagnostics
    • 4.4.1. Diagnostics Market, 2021 - 2033 (USD Million)
    • 4.4.2. Genetic Testing
      • 4.4.2.1. Genetic Testing Market, 2021 - 2033 (USD Million)
    • 4.4.3. Direct to Consumer Tests
      • 4.4.3.1. Direct to Consumer Tests Market, 2021 - 2033 (USD Million)
    • 4.4.4. Esoteric Tests
      • 4.4.4.1. Esoteric Tests Market, 2021 - 2033 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market, 2021 - 2033 (USD Million)
  • 4.5. Therapeutics
    • 4.5.1. Therapeutics Market, 2021 - 2033 (USD Million)
    • 4.5.2. Pharmaceuticals
      • 4.5.2.1. Pharmaceuticals Market, 2021 - 2033 (USD Million)
      • 4.5.2.2. Oncology
        • 4.5.2.2.1. Oncology Market, 2021 - 2033 (USD Million)
      • 4.5.2.3. Respiratory Disease
        • 4.5.2.3.1. Respiratory Disease Market, 2021 - 2033 (USD Million)
      • 4.5.2.4. Skin Disease
        • 4.5.2.4.1. Skin Disease Market, 2021 - 2033 (USD Million)
      • 4.5.2.5. CNS Disorders
        • 4.5.2.5.1. CNS Disorders Market, 2021 - 2033 (USD Million)
      • 4.5.2.6. Immunology
        • 4.5.2.6.1. Immunology Market, 2021 - 2033 (USD Million)
      • 4.5.2.7. Genetic Disease
        • 4.5.2.7.1. Genetic Disease Market, 2021 - 2033 (USD Million)
      • 4.5.2.8. Others
        • 4.5.2.8.1. Others Market, 2021 - 2033 (USD Million)
    • 4.5.3. Medical Devices
      • 4.5.3.1. Medical Devices Market, 2021 - 2033 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Precision Medicine Market: End Use Business Analysis

  • 5.1. End Use Market Share, 2025 & 2033
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by End use, 2021 to 2033 (USD Million)
  • 5.4. Home Care
    • 5.4.1. Home Care Market, 2021 - 2033 (USD Million)
  • 5.5. Hospitals
    • 5.5.1. Hospitals Market, 2021 - 2033 (USD Million)
  • 5.6. Clinical Laboratories
    • 5.6.1. Clinical Laboratories Market, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Precision Medicine Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2025 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America Precision Medicine Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Framework
      • 6.4.2.5. U.S. Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Framework
      • 6.4.3.5. Canada Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Reimbursement Framework
      • 6.4.4.5. Mexico Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Framework
      • 6.5.2.5. UK Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Framework
      • 6.5.3.5. Germany Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement Framework
      • 6.5.4.5. France Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Target Disease Prevalence
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Reimbursement Framework
      • 6.5.5.5. Italy Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Target Disease Prevalence
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Framework
      • 6.5.6.5. Spain Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Target Disease Prevalence
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Framework
      • 6.5.7.5. Denmark Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Target Disease Prevalence
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Framework
      • 6.5.8.5. Sweden Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Target Disease Prevalence
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement Framework
      • 6.5.9.5. Norway Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Framework
      • 6.6.2.5. Japan Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Framework
      • 6.6.3.5. China Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Framework
      • 6.6.4.5. India Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Framework
      • 6.6.5.5. Australia Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Target Disease Prevalence
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Framework
      • 6.6.6.5. South Korea Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Target Disease Prevalence
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Framework
      • 6.6.7.5. Thailand Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Target Disease Prevalence
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Framework
      • 6.7.2.5. Brazil Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Target Disease Prevalence
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Framework
      • 6.7.3.5. Argentina Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Middle East & Africa
    • 6.8.1. Middle East & Africa Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Target Disease Prevalence
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Framework
      • 6.8.2.5. South Africa Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Target Disease Prevalence
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Framework
      • 6.8.3.5. Saudi Arabia Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Target Disease Prevalence
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement Framework
      • 6.8.4.5. UAE Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Target Disease Prevalence
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement Framework
      • 6.8.5.5. Kuwait Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. F. Hoffmann-La Roche Ltd
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Siemens
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Janssen Global Services, LLC
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Illumina, Inc.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Quest Diagnostics Incorporated
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. 23andMe, Inc.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. NeoDiagnostix
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Myriad Genetics
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Medtronic
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. GE Healthcare
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives
    • 7.5.11. Abbott
      • 7.5.11.1. Overview
      • 7.5.11.2. Financial Performance
      • 7.5.11.3. Product Benchmarking
      • 7.5.11.4. Strategic Initiatives
    • 7.5.12. QIAGEN
      • 7.5.12.1. Overview
      • 7.5.12.2. Financial Performance
      • 7.5.12.3. Product Benchmarking
      • 7.5.12.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global precision medicine market, by region, 2021 - 2033 (USD Million)
  • Table 4. Global precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 5. Global precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 6. North America precision medicine market, by country, 2021 - 2033 (USD Million)
  • Table 7. North America precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 8. North America precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 9. U.S. precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 10. U.S. precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 11. Canada precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 12. Canada precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 13. Mexico precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 14. Mexico precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 15. Europe precision medicine market, by country, 2021 - 2033 (USD Million)
  • Table 16. Europe precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 17. Europe precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 18. UK precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 19. UK precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 20. Germany precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 21. Germany precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 22. France precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 23. France precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 24. Italy precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 25. Italy precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 26. Spain precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 27. Spain precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 28. Norway precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 29. Norway precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 30. Denmark precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 31. Denmark precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 32. Sweden precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 33. Sweden precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 34. Asia Pacific precision medicine market, by country, 2021 - 2033 (USD Million)
  • Table 35. Asia Pacific precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 36. Asia Pacific precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 37. Japan precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 38. Japan precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 39. China precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 40. China precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 41. India precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 42. India precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 43. Australia precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 44. Australia precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 45. South Korea precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 46. South Korea precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 47. Thailand precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 48. Thailand precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 49. Latin America precision medicine market, by country, 2021 - 2033 (USD Million)
  • Table 50. Latin America precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 51. Latin America precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 52. Brazil precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 53. Brazil precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 54. Argentina precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 55. Argentina precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 56. Middle East & Africa precision medicine market, by country, 2021 - 2033 (USD Million)
  • Table 57. Middle East & Africa precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 58. Middle East & Africa precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 59. South Africa precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 60. South Africa precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 61. Saudi Arabia precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 62. Saudi Arabia precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 63. UAE precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 64. UAE precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 65. Kuwait precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 66. Kuwait precision medicine market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Precision medicine market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape
  • Fig. 10 Precision medicine market dynamics
  • Fig. 11 Precision medicine market: Porter's five forces analysis
  • Fig. 12 Precision medicine market: PESTLE analysis
  • Fig. 13 Application market, 2021 - 2033 (USD Million)
  • Fig. 14 Diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 15 Genetic testing market, 2021 - 2033 (USD Million)
  • Fig. 16 Direct to consumer tests market, 2021 - 2033 (USD Million)
  • Fig. 17 Esoteric tests market, 2021 - 2033 (USD Million)
  • Fig. 18 Others market, 2021 - 2033 (USD Million)
  • Fig. 19 Therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 20 Pharmaceuticals market, 2021 - 2033 (USD Million)
  • Fig. 21 Oncology market, 2021 - 2033 (USD Million)
  • Fig. 22 Respiratory disease market, 2021 - 2033 (USD Million)
  • Fig. 23 Skin diseases market, 2021 - 2033 (USD Million)
  • Fig. 24 CNS disorders market, 2021 - 2033 (USD Million)
  • Fig. 25 Immunology market, 2021 - 2033 (USD Million)
  • Fig. 26 Genetic diseases market, 2021 - 2033 (USD Million)
  • Fig. 27 Others market, 2021 - 2033 (USD Million)
  • Fig. 28 Medical devices market, 2021 - 2033 (USD Million)
  • Fig. 29 Others market, 2021 - 2033 (USD Million)
  • Fig. 30 End use market, 2021 - 2033 (USD Million)
  • Fig. 31 Home care market, 2021 - 2033 (USD Million)
  • Fig. 32 Hospitals market, 2021 - 2033 (USD Million)
  • Fig. 33 Clinical laboratories market, 2021 - 2033 (USD Million)
  • Fig. 34 Others market, 2021 - 2033 (USD Million)
  • Fig. 35 Precision medicine market revenue, by region
  • Fig. 36 Regional marketplace: Key takeaways
  • Fig. 37 North America Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. country dynamics
  • Fig. 39 U.S. Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 40 Canada country dynamics
  • Fig. 41 Canada Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 42 Mexico country dynamics
  • Fig. 43 Mexico Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 44 Europe Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 45 UK country dynamics
  • Fig. 46 UK Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 47 Germany country dynamics
  • Fig. 48 Germany Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 49 France country dynamics
  • Fig. 50 France Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 51 Italy country dynamics
  • Fig. 52 Italy Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 53 Spain country dynamics
  • Fig. 54 Spain Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 55 Norway country dynamics
  • Fig. 56 Norway Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 57 Sweden country dynamics
  • Fig. 58 Sweden Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 59 Denmark country dynamics
  • Fig. 60 Denmark Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 61 Asia Pacific Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 62 Japan country dynamics
  • Fig. 63 Japan Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 64 China country dynamics
  • Fig. 65 China Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 66 India country dynamics
  • Fig. 67 India Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 68 Australia country dynamics
  • Fig. 69 Australia Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 70 South Korea country dynamics
  • Fig. 71 South Korea Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 72 Thailand country dynamics
  • Fig. 73 Thailand Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 74 Latin America Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 75 Brazil country dynamics
  • Fig. 76 Brazil Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 77 Argentina country dynamics
  • Fig. 78 Argentina Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 79 MEA Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 80 South Africa country dynamics
  • Fig. 81 South Africa Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 82 Saudi Arabia country dynamics
  • Fig. 83 Saudi Arabia Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 84 UAE country dynamics
  • Fig. 85 UAE Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 86 Kuwait country dynamics
  • Fig. 87 Kuwait Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 88 Company categorization
  • Fig. 89 Company market position analysis
  • Fig. 90 Strategic framework